Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- International Centre for Translational Eye Research / Institute of Physical Chemistry, Polish Academy of Sciences
- Karolinska Institutet
- Curtin University
- AcademicTransfer
- ETH Zurich
- Radboud University Medical Center (Radboudumc)
- SciLifeLab
- Delft University of Technology
- University of British Columbia
- Utrecht University
- ;
- ; Newcastle University
- ; University of Plymouth
- Aalborg University
- Centre for Genomic Regulation
- Erasmus MC (University Medical Center Rotterdam)
- Ghent University
- Hannover Medical School •
- Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
- Institute of Bioorganic Chemistry Polish Academy of Sciences
- KU Leuven
- Leibniz
- University of Nicosia Medical School
- Uppsala University
- ; Great Ormond Street Hospital for Children NHS Foundation Trust
- ; Loughborough University
- ; Swansea University
- ; The University of Manchester
- ; University of East Anglia
- ; University of Nottingham
- ; University of Sheffield
- ; University of Southampton
- ; University of Sussex
- Aix-Marseille University - CNRS
- Biomedical Campus Krč
- CNRS
- Carl von Ossietzky University of Oldenburg •
- Cranfield University
- Delft University of Technology (TU Delft)
- FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento
- Fraunhofer-Gesellschaft
- Hasselt University
- Heidelberg University
- Heinrich Heine University Düsseldorf •
- Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S)
- KNAW
- Karolinska Institutet, doctoral positions
- LMU Klinikum
- Leiden University
- Medical University of Lodz
- NIBRT
- Queensland University of Technology
- RMIT University
- Radboud University
- Radboudumc
- Stockholm University
- Swansea University
- Swinburne University of Technology
- Synklino
- Technical University of Denmark
- The Netherlands Cancer Institute
- The Norwegian School of Sport Sciences
- Trinity College Dublin
- UCLouvain
- Universitaet zu Luebeck
- University College Dublin
- University Medical Center Göttingen
- University Medical Centre Groningen (UMCG)
- University of Bergen
- University of Nottingham
- University of Salzburg
- University of Zimbabwe
- Université Claude Bernard Lyon1
- Université Libre de Bruxelles (ULB)
- Vrije Universiteit Amsterdam (VU)
- Wageningen University and Research Center
- 66 more »
- « less
-
Field
-
Molecular Geriatrics research group at the Department of Public Health and Caring Sciences is placed at the Rudbeck Laboratory. The group conducts several research projects focused on the therapy and
-
of their microbiota. This characterisation will help to predict the success of the biological therapy and thus has potential to tailor the appropriate therapy. Specific goals: 1) To identify consortia of bacteria
-
, Belgium) is looking for a highly motivated PhD student to unravel the cellular and molecular mechanisms underlying food reactivity and response to dietary and anti-inflammatory therapy in patients with
-
Human Norovirus Infection: a Key to Unlock New Therapies” (GlycoNoVi), funded by the European Commission. You will be analyzing the impact of glycans on human norovirus infection using state-of-the-art 3D
-
28th July 2024 Languages English English English Department of Sport and Social Sciences PhD position related to physical activity and prostate cancer Apply for this job See advertisement
-
Physics » Applied physics Physics » Other Researcher Profile First Stage Researcher (R1) Country Belgium Application Deadline 15 Jun 2024 - 21:59 (UTC) Type of Contract Temporary Job Status Full-time Hours
-
on the progression of hormone-dependent and hormone-independent cancers. We cooperates with Technical University of Lodz to design and use novel polymer-based radioisotope nanocarriers in cancer therapies. We
-
part of the GT4Health project, funded by the Walloon Region as part of its Win4Excellence program. It aims to develop various disruptive technologies as solutions to major challenges in the gene therapy
-
benefit from standard first-line therapy but promising individualized therapies such as CAR-T cell therapy are under development. To better asses which patients are eligible for new innovative therapies
-
tolerance and the presence of anti-neutrophil cytoplasmic autoantibodies (ANCA) contribute to tissue damage in AAV. While immunosuppressive therapies have improved outcomes, AAV remains a chronic and